Modulation of neutrophil granulocytes in the tumor microenvironment: Mechanisms and consequences for tumor progression

Seminars in Cancer Biology

Volumn 23, Issue 3, 2013, Pages 141-148

  Dumitru, Claudia A ^a   Lang, Stephan ^a   Brandau, Sven ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Inflammation; Neutrophils; Recruitment chemotaxis; Survival; Tumor progression

Indexed keywords

ARGINASE 1; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SERINE PROTEINASE; VASCULOTROPIN;

APOPTOSIS; CANCER SURVIVAL; CARCINOGENESIS; CELL ACTIVITY; CELL SURVIVAL; CYTOKINE RELEASE; HUMAN; IMMUNOMODULATION; INFLAMMATION; METASTASIS; MOLECULAR MECHANICS; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; REVIEW; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

ANIMALS; CELL SURVIVAL; CYTOKINES; DISEASE PROGRESSION; HUMANS; IMMUNOMODULATION; NEOPLASMS; NEUTROPHIL INFILTRATION; NEUTROPHILS; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84876956206     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2013.02.005     Document Type: Review

References (69)

1. Shoenfeld Y., Tal A., Berliner S., Pinkhas J. Leukocytosis in non hematological malignancies - a possible tumor-associated marker. Journal of Cancer Research and Clinical Oncology 1986, 111:54-58.
2. Halazun K.J., Aldoori A., Malik H.Z., Al-Mukhtar A., Prasad K.R., Toogood G.J., et al. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. European Journal of Surgical Oncology 2008, 34:55-60.
3. Halazun K.J., Hardy M.A., Rana A.A., Ct Woodland D., Luyten E.J., Mahadev S., et al. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Annals of Surgery 2009, 250:141-151.
4. Ohno Y., Nakashima J., Ohori M., Hatano T., Tachibana M. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. Journal of Urology 2010, 184:873-878.
5. Shimada H., Takiguchi N., Kainuma O., Soda H., Ikeda A., Cho A., et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer 2010, 13:170-176.
6. Cho H., Hur H.W., Kim S.W., Kim S.H., Kim J.H., Kim Y.T., et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunology, Immunotherapy 2009, 58:15-23.
7. An X., Ding P.R., Wang F.H., Jiang W.Q., Li Y.H. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma. Tumour Biology 2011, 32:317-324.
8. Jensen H.K., Donskov F., Marcussen N., Nordsmark M., Lundbeck F., von der Maase H. Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. Journal of Clinical Oncology 2009, 27:4709-4717.
9. Kuang D.M., Zhao Q., Wu Y., Peng C., Wang J., Xu Z., et al. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. Journal of Hepatology 2011, 54:948-955.
10. Li Y.W., Qiu S.J., Fan J., Zhou J., Gao Q., Xiao Y.S., et al. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection. Journal of Hepatology 2011, 54:497-505.
11. Ilie M., Hofman V., Ortholan C., Bonnetaud C., Coelle C., Mouroux J., et al. Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer. Cancer 2012, 118:1726-1737.
12. Jensen T.O., Schmidt H., Moller H.J., Donskov F., Hoyer M., Sjoegren P., et al. Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma. Cancer 2012, 118:2476-2485.
13. Trellakis S., Bruderek K., Dumitru C.A., Gholaman H., Gu X., Bankfalvi A., et al. Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. International Journal of Cancer 2011, 129:2183-2193.
14. Fossati G., Ricevuti G., Edwards S.W., Walker C., Dalton A., Rossi M.L. Neutrophil infiltration into human gliomas. Acta Neuropathologica 1999, 98:349-354.
15. Zhao J.J., Pan K., Wang W., Chen J.G., Wu Y.H., Lv L., et al. The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection. PLoS One 2012, 7:e33655.
16. Rao H.L., Chen J.W., Li M., Xiao Y.B., Fu J., Zeng Y.X., et al. Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis. PLoS One 2012, 7:e30806.
17. Dumitru C.A., Gholaman H., Trellakis S., Bruderek K., Dominas N., Gu X., et al. Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. International Journal of Cancer 2011, 129:859-869.
18. Wu Y., Zhao Q., Peng C., Sun L., Li X.F., Kuang D.M. Neutrophils promote motility of cancer cells via a hyaluronan-mediated TLR4/PI3K activation loop. Journal of Pathology 2011, 225:438-447.
19. Strell C., Lang K., Niggemann B., Zaenker K.S., Entschladen F. Neutrophil granulocytes promote the migratory activity of MDA-MB-468 human breast carcinoma cells via ICAM-1. Experimental Cell Research 2010, 316:138-148.
20. Shamamian P., Schwartz J.D., Pocock B.J., Monea S., Whiting D., Marcus S.G., et al. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. Journal of Cellular Physiology 2001, 189:197-206.
21. Queen M.M., Ryan R.E., Holzer R.G., Keller-Peck C.R., Jorcyk C.L. Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Research 2005, 65:8896-8904.
22. Imai Y., Kubota Y., Yamamoto S., Tsuji K., Shimatani M., Shibatani N., et al. Neutrophils enhance invasion activity of human cholangiocellular carcinoma and hepatocellular carcinoma cells: an in vitro study. Journal of Gastroenterology and Hepatology 2005, 20:287-293.
23. Tazawa H., Okada F., Kobayashi T., Tada M., Mori Y., Une Y., et al. Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. The American Journal of Pathology 2003, 163:2221-2232.
24. Spicer J.D., McDonald B., Cools-Lartigue J.J., Chow S.C., Giannias B., Kubes P., et al. Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells. Cancer Research 2012, 72:3919-3927.
25. Psaila B., Lyden D. The metastatic niche: adapting the foreign soil. Nature Reviews Cancer 2009, 9:285-293.
26. Yan H.H., Pickup M., Pang Y., Gorska A.E., Li Z., Chytil A., et al. Gr-1+CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung. Cancer Research 2010, 70:6139-6149.
27. Kowanetz M., Wu X., Lee J., Tan M., Hagenbeek T., Qu X., et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:21248-21255.
28. Sceneay J., Chow M.T., Chen A., Halse H.M., Wong C.S., Andrews D.M., et al. Primary tumor hypoxia recruits CD11b+/Ly6Cmed/Ly6G+ immune suppressor cells and compromises NK cell cytotoxicity in the premetastatic niche. Cancer Research 2012, 72:3906-3911.
29. Tazzyman S., Barry S.T., Ashton S., Wood P., Blakey D., Lewis C.E., et al. Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth. International Journal of Cancer 2011, 129:847-858.
30. Wada Y., Yoshida K., Tsutani Y., Shigematsu H., Oeda M., Sanada Y., et al. Neutrophil elastase induces cell proliferation and migration by the release of TGF-alpha, PDGF and VEGF in esophageal cell lines. Oncology Reports 2007, 17:161-167.
31. Giese A., Bjerkvig R., Berens M.E., Westphal M. Cost of migration: invasion of malignant gliomas and implications for treatment. Journal of Clinical Oncology 2003, 21:1624-1636.
32. Jung A., Schrauder M., Oswald U., Knoll C., Sellberg P., Palmqvist R., et al. The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. American Journal of Pathology 2001, 159:1613-1617.
33. Dumitru C.A., Moses K., Trellakis S., Lang S., Brandau S. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunology, Immunotherapy 2012, 61:1155-1167.
34. Fridlender Z.G., Sun J., Kim S., Kapoor V., Cheng G., Ling L., et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: N1 versus N2 TAN. Cancer Cell 2009, 16:183-194.
35. Rotondo R., Barisione G., Mastracci L., Grossi F., Orengo A.M., Costa R., et al. IL-8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer. International Journal of Cancer 2009, 125:887-893.
36. De Larco J.E., Wuertz B.R., Furcht L.T. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clinical Cancer Research 2004, 10:4895-4900.
37. Knaapen A.M., Gungor N., Schins R.P., Borm P.J., Van Schooten F.J. Neutrophils and respiratory tract DNA damage and mutagenesis: a review. Mutagenesis 2006, 21:225-236.
38. Weitzman S.A., Stossel T.P. Phagocyte-induced mutation in Chinese hamster ovary cells. Cancer Letters 1984, 22:337-341.
39. Weitzman S.A., Weitberg A.B., Clark E.P., Stossel T.P. Phagocytes as carcinogens: malignant transformation produced by human neutrophils. Science 1985, 227:1231-1233.
40. Auten R.L., Whorton M.H., Nicholas M.S. Blocking neutrophil influx reduces DNA damage in hyperoxia-exposed newborn rat lung. American Journal of Respiratory Cell and Molecular Biology 2002, 26:391-397.
41. McDonald B., Kubes P. Cellular and molecular choreography of neutrophil recruitment to sites of sterile inflammation. Journal of Molecular Medicine (Berl) 2011, 89:1079-1088.
42. Lazennec G., Richmond A. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends in Molecular Medicine 2010, 16:133-144.
43. Hannelien V., Karel G., Jo V.D., Sofie S. The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochimica et Biophysica Acta 2012, 1825:117-129.
44. Waugh D.J., Wilson C. The interleukin-8 pathway in cancer. Clinical Cancer Research 2008, 14:6735-6741.
45. Zhou S.L., Dai Z., Zhou Z.J., Wang X.Y., Yang G.H., Wang Z., et al. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology 2012, 56:2242-2254.
46. Okabe H., Beppu T., Ueda M., Hayashi H., Ishiko T., Masuda T., et al. Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts. International Journal of Cancer 2012, 131:2234-2241.
47. Gao Q., Zhao Y.J., Wang X.Y., Qiu S.J., Shi Y.H., Sun J., et al. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma. Cancer Research 2012, 72:3546-3556.
48. Bernhagen J., Krohn R., Lue H., Gregory J.L., Zernecke A., Koenen R.R., et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nature Medicine 2007, 13:587-596.
49. Florey O., Haskard D.O. Sphingosine 1-phosphate enhances Fc gamma receptor-mediated neutrophil activation and recruitment under flow conditions. Journal of Immunology 2009, 183:2330-2336.
50. Gault C.R., Obeid L.M. Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy. Critical Reviews in Biochemistry and Molecular Biology 2011, 46:342-351.
51. Jamieson N.B., Carter C.R., McKay C.J., Oien K.A. Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Clinical Cancer Research 2011, 17:3316-3331.
52. Tang D., Kang R., Zeh H.J., Lotze M.T. High-mobility group box 1 and cancer. Biochimica et Biophysica Acta 2010, 1799:131-140.
53. Orlova V.V., Choi E.Y., Xie C., Chavakis E., Bierhaus A., Ihanus E., et al. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO Journal 2007, 26:1129-1139.
54. Ryckman C., Vandal K., Rouleau P., Talbot M., Tessier P.A. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. Journal of Immunology 2003, 170:3233-3242.
55. Luo H.R., Loison F. Constitutive neutrophil apoptosis: mechanisms and regulation. American Journal of Hematology 2008, 83:288-295.
56. Dumitru C.A., Fechner M.K., Hoffmann T.K., Lang S., Brandau S. A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer. Journal of Leukocyte Biology 2012, 91:591-598.
57. Trellakis S., Farjah H., Bruderek K., Dumitru C.A., Hoffmann T.K., Lang S., et al. Peripheral blood neutrophil granulocytes from patients with head and neck squamous cell carcinoma functionally differ from their counterparts in healthy donors. International Journal of Immunopathology & Pharmacology 2011, 24:683-693.
58. Joshita S., Nakazawa K., Sugiyama Y., Kamijo A., Matsubayashi K., Miyabayashi H., et al. Granulocyte-colony stimulating factor-producing pancreatic adenosquamous carcinoma showing aggressive clinical course. Internal Medicine 2009, 48:687-691.
59. Nakada T., Sato H., Inoue F., Mizorogi F., Nagayama K., Tanaka T. The production of colony-stimulating factors by thyroid carcinoma is associated with marked neutrophilia and eosinophilia. Internal Medicine 1996, 35:815-820.
60. + T cells. Journal of Leukocyte Biology 2010, 88:1163-1170.
61. Glynn P.C., Henney E., Hall I.P. The selective CXCR2 antagonist SB272844 blocks interleukin-8 and growth-related oncogene-alpha-mediated inhibition of spontaneous neutrophil apoptosis. Pulmonary Pharmacology and Therapeutics 2002, 15:103-110.
62. Chihab R., Porn-Ares M.I., Alvarado-Kristensson M., Andersson T. Sphingosine 1-phosphate antagonizes human neutrophil apoptosis via p38 mitogen-activated protein kinase. Cellular and Molecular Life Sciences 2003, 60:776-785.
63. Hannah S., Mecklenburgh K., Rahman I., Bellingan G.J., Greening A., Haslett C., et al. Hypoxia prolongs neutrophil survival in vitro. FEBS Letters 1995, 372:233-237.
64. Walmsley S.R., Print C., Farahi N., Peyssonnaux C., Johnson R.S., Cramer T., et al. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. Journal of Experimental Medicine 2005, 201:105-115.
65. Borregaard N., Sorensen O.E., Theilgaard-Monch K. Neutrophil granules: a library of innate immunity proteins. Trends in Immunology 2007, 28:340-345.
66. Brandau S., Dumitru C.A., Lang S. Protumor and antitumor functions of neutrophil granulocytes. Semin Immunopathol 2012, 10.1007/s00281-012-0344-6.
67. Wislez M., Rabbe N., Marchal J., Milleron B., Crestani B., Mayaud C., et al. Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. Cancer Research 2003, 63:1405-1412.
68. Peng H.H., Liang S., Henderson A.J., Dong C. Regulation of interleukin-8 expression in melanoma-stimulated neutrophil inflammatory response. Experimental Cell Research 2007, 313:551-559.
69. Jablonska J., Leschner S., Westphal K., Lienenklaus S., Weiss S. Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model. Journal of Clinical Investigation 2010, 120:1151-1164.